75 related articles for article (PubMed ID: 23256610)
1. Prognostic significance of thyroid or cricoid cartilage invasion in laryngeal or hypopharyngeal cancer treated with organ preserving strategies.
Wagner MM; Curé JK; Caudell JJ; Spencer SA; Nabell LM; Carroll WR; Bonner JA
Radiat Oncol; 2012 Dec; 7():219. PubMed ID: 23256610
[TBL] [Abstract][Full Text] [Related]
2. Definitive intensity modulated radiotherapy in locally advanced hypopharygeal and laryngeal squamous cell carcinoma: mature treatment results and patterns of locoregional failure.
Geretschläger A; Bojaxhiu B; Dal Pra A; Leiser D; Schmücking M; Arnold A; Ghadjar P; Aebersold DM
Radiat Oncol; 2015 Jan; 10():20. PubMed ID: 25595218
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus-associated squamous cell carcinoma of the larynx or hypopharynx: Clinical outcomes and implications for laryngeal preservation.
Hughes RT; Beuerlein WJ; O'Neill SS; Porosnicu M; Lycan TW; Waltonen JD; Frizzell BA; Greven KM
Oral Oncol; 2019 Nov; 98():20-27. PubMed ID: 31536842
[TBL] [Abstract][Full Text] [Related]
4. PD-1 Inhibitors combined with paclitaxel (Albumin-bound) and cisplatin for larynx preservation in locally advanced laryngeal and hypopharyngeal squamous cell carcinoma: a retrospective study.
Fang Q; Xu P; Cao F; Wu D; Liu X
Cancer Immunol Immunother; 2023 Dec; 72(12):4161-4168. PubMed ID: 37804437
[TBL] [Abstract][Full Text] [Related]
5. Thyroid cartilage infiltration in advanced laryngeal cancer: prognostic implications and predictive modelling.
Montenegro C; Paderno A; Ravanelli M; Pessina C; Nassih FE; Lancini D; Del Bon F; Mattavelli D; Farina D; Piazza C
Acta Otorhinolaryngol Ital; 2024 Jun; 44(3):176-182. PubMed ID: 38165207
[TBL] [Abstract][Full Text] [Related]
6. Outcomes for Organ Preservation with Chemoradiation Therapy for T4 Larynx and Hypopharynx Cancer.
Eita A; Mohamed N; Rybkin A; Kang JJ; Fiasconaro M; Zhigang Z; Zakeri K; Yu Y; Sadaka E; Sherman E; Dunn L; Cracchiolo J; Wong RJ; Cohen M; Lee NY
Laryngoscope; 2023 May; 133(5):1138-1145. PubMed ID: 35801573
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional imaging assessment of anatomic invasion and volumetric considerations for chemo/radiotherapy-based laryngeal preservation in T3 larynx cancer.
Kamal M; Ng SP; Eraj SA; Rock CD; Pham B; Messer JA; Garden AS; Morrison WH; Phan J; Frank SJ; El-Naggar AK; Johnson JM; Ginsberg LE; Ferrarotto R; Lewin JS; Hutcheson KA; Cardenas CE; Zafereo ME; Lai SY; Hessel AC; Weber RS; Gunn GB; Fuller CD; Mohamed ASR; Rosenthal DI
Oral Oncol; 2018 Apr; 79():1-8. PubMed ID: 29598944
[TBL] [Abstract][Full Text] [Related]
8. [Postoperative prognostic risk factors and treatment strategies for patients with T3-T4 hypopharyngeal squamous cell carcinoma].
Tao L; Zhou L; Zhang M; Wu H; Li X; Chen X; Li C; Shi Y; Cheng L; Lin H
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 May; 35(5):400-404;409. PubMed ID: 34304462
[No Abstract] [Full Text] [Related]
9. Factors Influencing Postoperative Prognosis in Patients with Hypopharyngeal and Laryngeal Carcinoma.
Chen J; Liang N; Sun C; Zhang L; Yi T; Liao Q; Zhou S
Ear Nose Throat J; 2023 Dec; 102(12):794-802. PubMed ID: 36427261
[TBL] [Abstract][Full Text] [Related]
10. The influence of smoking, age and stage at diagnosis on the survival after larynx, hypopharynx and oral cavity cancers in Europe: The ARCAGE study.
Abrahão R; Anantharaman D; Gaborieau V; Abedi-Ardekani B; Lagiou P; Lagiou A; Ahrens W; Holcatova I; Betka J; Merletti F; Richiardi L; Kjaerheim K; Serraino D; Polesel J; Simonato L; Alemany L; Agudo Trigueros A; Macfarlane TV; Macfarlane GJ; Znaor A; Robinson M; Canova C; Conway DI; Wright S; Healy CM; Toner M; Cadoni G; Boccia S; Gheit T; Tommasino M; Scelo G; Brennan P
Int J Cancer; 2018 Jul; 143(1):32-44. PubMed ID: 29405297
[TBL] [Abstract][Full Text] [Related]
11. Hypopharyngeal carcinoma in Finland from 2005 to 2014: outcome remains poor after major changes in treatment.
Keski-Säntti H; Luukkaa M; Carpén T; Jouppila-Mättö A; Lehtiö K; Mäenpää H; Vuolukka K; Vahlberg T; Mäkitie A
Eur Arch Otorhinolaryngol; 2023 Mar; 280(3):1361-1367. PubMed ID: 36094562
[TBL] [Abstract][Full Text] [Related]
12. Peripheral lymphocyte count as an indicator of radiotherapy effectiveness in hypopharyngeal squamous cell carcinoma.
Lin H; Gao C; Heng Y; Zhu X; Wang T; Zhou L; Zhang M; Wu C; Tao L
Clin Otolaryngol; 2024 Jul; 49(4):436-444. PubMed ID: 38596906
[TBL] [Abstract][Full Text] [Related]
13. Treatment outcomes and cost comparisons for older adults with T4 laryngeal squamous cell cancer.
McDermott JD; Amini A; Molina E; Stokes WA; Karam SD
Head Neck; 2023 Mar; 45(3):664-674. PubMed ID: 36563300
[TBL] [Abstract][Full Text] [Related]
14. Risk factors of secondary cancer in laryngeal, oropharyngeal, or hypopharyngeal cancer after definitive therapy.
Nishimura G; Takahashi H; Sano D; Arai Y; Hatano T; Kitani Y; Oridate N
Int J Clin Oncol; 2024 Feb; 29(2):103-114. PubMed ID: 38057500
[TBL] [Abstract][Full Text] [Related]
15. Clinical predictors of premature radiotherapy terminations in senior adults with oral cavity and laryngeal carcinoma.
Cooper DJ; Travaglia I; Guller M; Talcott WJ; Ghaly M; Miles BA; Frank D; Seetharamu N; Parashar B
Head Neck; 2024 Feb; 46(2):262-268. PubMed ID: 37950590
[TBL] [Abstract][Full Text] [Related]
16. Clinical factors associated with severe surgical complications in patients with hypopharyngeal cancer: a single-center case-cohort study.
Liu YH; Huang H; Yan DG; Ni S; Liu SY
Acta Otolaryngol; 2023 Oct; 143(10):918-924. PubMed ID: 37982754
[TBL] [Abstract][Full Text] [Related]
17. Routes to diagnosis of hypopharyngeal cancer: A single-centre experience.
Pearce H; Hamilton D; Sharp L; Deane J; Kennedy M; O'Hara J
Clin Otolaryngol; 2024 Jul; 49(4):495-499. PubMed ID: 38515125
[No Abstract] [Full Text] [Related]
18. T4a laryngeal cancer survival: retrospective institutional analysis and systematic review.
Francis E; Matar N; Khoueir N; Nassif C; Farah C; Haddad A
Laryngoscope; 2014 Jul; 124(7):1618-23. PubMed ID: 24338374
[TBL] [Abstract][Full Text] [Related]
19. Establishing safe high hydrostatic pressure devitalization thresholds for autologous head and neck cancer vaccination and reconstruction.
Maletzki C; Freiin Grote V; Kalle F; Kleitke T; Zimpfer A; Becker AS; Bergmann-Ewert W; Jonitz-Heincke A; Bader R; Vollmar B; Hackenberg S; Scherzad A; Mlynski R; Strüder D
Cell Death Discov; 2023 Oct; 9(1):390. PubMed ID: 37872173
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
